Episode Details
Back to EpisodesMedicare Limitation of Aduhelm
Published 3 years, 6 months ago
Description
Dr. Ron Petersen, Director of the Mayo Clinic Alzheimer's Disease Research Center, discusses Medicare's recent decision to officially limit Aduhelm (aducanumab) coverage to patients in clinical trials.
Read the full article discussed in this interview in the New York Times.